Chemical composition, antibacterial activity and effect of Rhus albida Schousb essential oil on the inhibition of NorA efflux pump in Staphylococcus aureus

Human infectious diseases once treatable with antibiotics are now becoming a serious life-threatening problem due to the emergence of multidrug resistant (MDR) micro-organisms. For this, essential oils (EOs) could constitute a viable source of bioactive compounds capable of inhibiting the mechanisms of this antimicrobial resistance. In this context, our goals were to determine for the first time the chemical composition of EO extracted from aerial parts of Rhus albida, its antibacterial and synergistic interactions with fluoroquinolones and finally to evaluate its ability to inhibit the Staphylococcus aureus NorA efflux pump. The chemical profile and antibacterial activity of R. albida EO were determined using Gas Chromatography coupled to Mass Spectrometry and microdilution assays, respectively. While its NorA efflux-pump-inhibiting activity was assessed using a fluorescent real-time efflux method (based on ethidium bromide (EtBr)) against two S. aureus strains: a NorA overproducing strain (SA1199B) and a wild type strain (SA1199). Results showed that the EO, which is characterized by the abundance sesquiterpenes (δ-cadinene (15.6%), α-copaene (6.3%) and caryophyllene (6.2%)), displayed moderate antimicrobial activities against both SA1199 and SA1199B (MIC = 2048 µg/mL). Nevertheless, its combination with fluoroquinolones contributed to the reduction of their intrinsic MICs only against SA1199B by 4- to 8-fold. Furthermore, the EO at 1/32 MIC, contributed to a large accumulation of EtBr and inhibition of its efflux in SA1199B. Our findings demonstrated the ability of R. albida EO to inhibit the NorA efflux pump. Thus, further studies should be performed in order to make the combination of this natural product with approved antimicrobials a viable option for future administrations in infections with S. aureus strains overproducing NorA EPs.